Tagged with innovation,

Saudi Arabia Amgad Talaat, Regional Cluster Head of EVA Pharma Saudi Arabia, delves into the company’s strategic expansion in the region, emphasizing investments in local manufacturing, innovation, and team development to align with Saudi Vision 2030. With a focus on addressing unmet medical needs and fostering partnerships, EVA Pharma is positioning itself…

China US-headquartered global genomic sequencing giant Illumina has endured a tough few years. However, now that various legal wrangles over its acquisition of cancer diagnostics developer GRAIL have been largely resolved and with a new global CEO in place, the firm has outlined a new growth strategy and is predicting high…

Switzerland Industry stakeholders are raising the alarm about access to innovative medicines in Switzerland. Do delays in market access compared to other countries in Europe not only threaten the health of patients in Switzerland, but the country’s status as a global biopharmaceutical R&D hub?   Major Challenges As outlined elsewhere in…

Switzerland Although the global biotech sector is currently struggling with equity and debt financing, Swiss biotech is on the up. 2023 saw the Swiss biotech sector hit record revenues of CHF 7.3 billion (EUR 7.8 billion) with capital investments surpassing CHF 2 billion. While funding inflows still did not reach the…

Puerto Rico Lucy Crespo, CEO of the Puerto Rico Science Technology and Research Trust, highlights significant recent advancements in establishing Puerto Rico as a global innovation hub, including the recent designation of Puerto Rico as one of the US Economic Development Administration’s technology hubs (Tech Hubs) and the opening of the island’s…

Switzerland David Traub, General Manager of Novartis in its home country of Switzerland, reflects on his journey to Novartis, emphasizing the need for innovation in Swiss healthcare. He discusses challenges in access to innovative medicines and the importance of healthcare digitalization, calling for bold reforms. Traub aims to collaborate with stakeholders…

Mexico Carlos Escobar highlights his extensive career journey at Baxter/Vantive, emphasizing the company’s commitment to enhancing patient care through innovative technologies in Mexico and Latin America. He discusses the shift towards multi-organ support, the importance of digitalization in healthcare, and the need for a strong organizational culture to drive value.  …

Saudi Arabia Ashraf Daoud lays out how AbbVie is fully aligned with Saudi Arabia’s Vision 2030, focusing on innovation, partnerships with governmental bodies, and local talent development to drive healthcare transformation. He explains why the establishment of AbbVie’s regional headquarters in Saudi Arabia highlights the country’s importance in the Middle East, aiming…

Mexico The lowest spender on healthcare as a percentage of GDP in mainland Latin America. A complex and fragmented reimbursement system. Clinical trial approval delays stretching across eight months. One could be forgiven for thinking that attempting to bring innovative medicines to Mexico is a thankless task. Yet, as several country…

Switzerland Dr René Buholzer, CEO of Interpharma, covers Switzerland’s healthcare advancements, regulatory progress, and the challenges in drug access and digitalization over the past three years. Emphasising collaboration and innovation, Interpharma’s ‘Pharma Strategy 2030’ aims to solidify Switzerland’s leadership in R&D and healthcare sustainability.   Our vision is not just about…

Switzerland Swiss Biotech’s Michael Altorfer explains how Switzerland’s biotech industry continues to grow, driven by startups and SMEs and supported by strong international collaborations across the entire value chain. He outlines how Swissmedic’s proactive approach to advanced therapies and participation in the Access Consortium enables faster and more efficient drug approval…

Switzerland Katharina Gasser of Roche Pharma Switzerland lays out her dedication to fostering innovation, strengthening team dynamics, and influencing the future of Switzerland’s healthcare landscape. Gasser emphasizes the need to combat complacency, advance digitalization, and promote diversity in leadership, noting that “complacency is a real threat—it stifles innovation, diminishes drive, and…